- Home
- LSTA vs IPA Comparison
LSTA vs IPA Comparison
Compare LSTA & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- IPA
- Stock Information
- Founded
- LSTA 1980
- IPA 1983
- Country
- LSTA United States
- IPA United States
- Employees
- LSTA N/A
- IPA N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- LSTA Health Care
- IPA Health Care
- Exchange
- LSTA Nasdaq
- IPA Nasdaq
- Market Cap
- LSTA 20.0M
- IPA 20.6M
- IPO Year
- LSTA N/A
- IPA 2017
- Fundamental
- Price
- LSTA $2.18
- IPA $0.50
- Analyst Decision
- LSTA Strong Buy
- IPA Strong Buy
- Analyst Count
- LSTA 1
- IPA 2
- Target Price
- LSTA $15.00
- IPA $4.00
- AVG Volume (30 Days)
- LSTA 10.9K
- IPA 341.2K
- Earning Date
- LSTA 05-08-2025
- IPA 03-28-2025
- Dividend Yield
- LSTA N/A
- IPA N/A
- EPS Growth
- LSTA N/A
- IPA N/A
- EPS
- LSTA N/A
- IPA N/A
- Revenue
- LSTA $1,000,000.00
- IPA $16,581,105.00
- Revenue This Year
- LSTA N/A
- IPA $4.67
- Revenue Next Year
- LSTA N/A
- IPA $14.15
- P/E Ratio
- LSTA N/A
- IPA N/A
- Revenue Growth
- LSTA N/A
- IPA 1.34
- 52 Week Low
- LSTA $1.87
- IPA $0.27
- 52 Week High
- LSTA $4.20
- IPA $1.36
- Technical
- Relative Strength Index (RSI)
- LSTA 44.79
- IPA 61.95
- Support Level
- LSTA $2.07
- IPA $0.44
- Resistance Level
- LSTA $2.46
- IPA $0.48
- Average True Range (ATR)
- LSTA 0.17
- IPA 0.03
- MACD
- LSTA -0.02
- IPA 0.00
- Stochastic Oscillator
- LSTA 22.92
- IPA 85.21
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.